Chronic β1-adrenoceptor blockade sensitises the H1 and H2 receptor systems in human atrium: Rôle of cyclic nucleotides

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 353, Issue 6, 1996, Pages 661-670

  Sanders, Louise ^a   Lynham, James A ^a   Kaumann, Alberto J ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Arrhythmias; Chronic adrenoceptor blockade; Contractile force; Cyclic AMP and cyclic GMP; Histamine1 and histamine2 receptor hyperresponsiveness; Human atrium; Phosphodiesterase 3; Protein kinase A

Indexed keywords

5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; AMILORIDE; AMLODIPINE; ATENOLOL; BENDROFLUMETHIAZIDE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FAMOTIDINE; FUROSEMIDE; GLYCERYL TRINITRATE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCHLOROTHIAZIDE; ISOSORBIDE MONONITRIATE; LISOPROLOL; MEPYRAMINE; METOPROLOL; NADOLOL; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE III; TIMOLOL; TRIAMTERENE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG USE; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM CONTRACTILITY; HEART ATRIUM PACING; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; ISOLATED HEART; MALE; SENSITIZATION;

ADRENERGIC BETA-ANTAGONISTS; ARRHYTHMIA; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FAMOTIDINE; FEMALE; HEART; HEART ATRIA; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PYRILAMINE; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; STIMULATION, CHEMICAL;

EID: 0030001397     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00167185     Document Type: Article

References (43)

1. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonism. Br J Pharmacol 14:48-58
2. Beavo JA (1988) Multiple isoenzymes of cyclic nucleoside phosphodiesterases. Adv Second Messenger Res 22:1-38
3. Beavo JA, Reifsnyder DH (1990) Primary sequence of cyclic nucleoside phosphodiesterase isocnzymes and the design of selective inhibitors. Trends Pharmacol Sci 11:150-155
4. Beavo JA, Conti M, Heaslip RJ (1994) Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 46:399-405
5. 2-receptor antagonists on the mouse isolated stomach assay. Br J Pharmacol 86:581-587
6. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
7. Brady AJB, Warren JB, Poole-Wilson A, Williams TJ, Harding SE (1993) Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265 (Heart Circ Physiol 34):H176-H182
8. Bristow MR, Cubicciotti R, Stinson EB, Johnson C (1982) Histamine-mediated adenylate cyclase stimulation in human myocardium. Mol Pharmacol 21:671-679
9. 2-adrenoceplors. Eur J Pharmacol 130:137-139
10. Eckel L, Gristwood RW, Nawrath H, Owen DAA, Satter P (1982) Inotropic and electrophysiological effects of histamine on human ventricular heart muscle. J Physiol 330:111-123
11. 1-mediated negative chronotropic and inotropic effects on human atrial myocardium. J Pharmacol Exp Ther 247:844-849
12. 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by ( )-noradrenaline and ( )-adrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 331:60-70
13. Ginsburg R, Bristow ME, Stinson EB, Harrison DC (1980) Histamine receptors in the human heart. Life Sci 26:2245-2249
14. Gristwood RW, Lincoln JCR, Owen DAA, Smith IR (1981) Histamine release from human right atrium. Br J Pharmacol 74:7-9
15. Guo Z-G, Levi R, Graver M, Robertson D, Gay WA (1984) Inotropic effects of histamine in human myocardium: differentiation between positive and negative components. J Cardiovasc Pharmacol 6:1210-1215
16. 2-adrenoceptors in human atrial myocardium. Circ Res 66:1610-1623
17. 2-receptors on contractility, spontaneous rale and cyclic nucleotides in the rabbit heart. Eur J Pharmacol 153:221-229
18. 2-adrenoceptors activated by ( )-adrenaline in rat sinoatrial node. Naunyn-Schmiedcberg's Arch Pharmacol 332:406-409
19. Kaumann AJ (1991a) Regulation of cardiac β-adrenoceptors by antagonists. In: Szabadi E, Bradshaw CM (eds) Adrenoceptors: structure, mechanisms, function. Advances in pharmacological sciences. Birkhauser, Basel pp 221-230
20. Kaumann AJ (1991b) Some aspects of heart βi-adrenoceptor function. Cardiovasc Drugs Ther 5:549-560
21. 4 receptors mediate arrhythmias? Trends Pharmacol Sci 15:451-455
22. Kaumann AJ, Lemoine H (1987) β-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium: Quantitative discrepancies with binding and adenylate cyclase stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 335: 403-411
23. 2-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human atrium. Naunyn-Schmiedeberg's Arch Pharmacol 348:536-540
24. 4 receptors in human atrium: facilitation by chronic β-adrenoceptor blockade. Naunyn-Schmiedeberg's Arch Pharmacol 349:331-337
25. 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J 10 [Suppl B]:29-37
26. 4-like receptor in human right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 344:150-159
27. Kirstein M, Rivet-Bastide M, Hatem S, Benardeau A, Mercadier J-J, Fischmeister R (1995) Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest 95:794-802
28. Levi R (1988) Cardiac anaphylaxis: models, mediators, mechanisms and clinical considerations. In: Marons G, Lichtenstein L, Condorelli M, Fauci A (eds) Human inflammatory disease. Decker, Toronto Canada, pp 93-105
29. Levi R, Malm JR, Bowman FO, Rosen MR (1981) The arrhythmogenic actions of histamine on human atrial fibers. Circ Res 49:545-550
30. 2-adrenoceptors in the human heart by chronic β-adrenoceptor antagonist treatment. Br J Pharmacol 94:685-692
31. 2 muscarinic receptors in human rinht atrium. Br J Pharmacol 101:363-369
32. 2+ current in guinea-pig ventricular cells. J Physiol 443:387-404
33. 1-receptor in heart: unique clectrophoretic mobility and autoradiographic localization. J Neurochem 55:379-385
34. 1-receptor-induced stimulation of phosphoinositide turnover. J Pharmacol Exp Ther 247:466-472
35. 4 receptors by chronic β blocker treatment. Circulation 92:2526-2539
36. Schulz R, Smith JA, Lewis MJ, Moncada S (1991) Nitric oxide synthase in cultured endocardial cells of the pig. Br J Pharmacol 104:21-24
37. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105:575-580
38. Siegel S (1956) Nonparametric statistics for the behavioral sciences. McGraw Hill, New York, pp 95-110
39. Smith JA, Shah AM, Lewis MJ (1991) Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol 439:1-14
40. Sugioka M, Ito M, Masuoka H, Ichikawa K, Konishi T, Tanaka T, Nakano T (1994) Identification and characterization of isoenzymes of cyclic nucleotide phosphodiesterase in human kidney and heart, and the effects of new cardiotonic agents on these isoenzymes. Naunyn-Schmiedeberg's Arch Pharmacol 350: 284-293
41. von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Schmilz W, Scholz H, Starbatty J, Stein B, Wenzlaff H, Döring V, Kalmar P, Haverich A (1991) Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfatling human cardiac muscle preparations. Naunyn-Schmiedeberg's Arch Pharmacol 344:90-100
42. Wolff AA, Levi R (1986) Histamine and cardiac arrhythmias. Circ Res 58:1-15
43. Zerkowski H-R, Broede A, Kunde K, Hillemann S, Schafer E, Vogelsang M, Michel MC, Brodde O-E (1993) Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 347:347-352